Connor Clark & Lunn Investment Management Ltd. bought a new stake in Proto Labs, Inc. (NYSE:PRLB – Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 120,473 shares of the industrial products company’s stock, valued at approximately $9,820,000. Connor Clark & Lunn Investment Management Ltd. owned about 0.50% of Proto Labs as of its most recent filing with the SEC.
Other institutional investors have also recently bought and sold shares of the company. Illinois Municipal Retirement Fund boosted its position in Proto Labs by 2.4% during the 1st quarter. Illinois Municipal Retirement Fund now owns 12,871 shares of the industrial products company’s stock worth $734,000 after acquiring an additional 300 shares during the last quarter. Horizon Investments LLC raised its holdings in shares of Proto Labs by 3.4% in the fourth quarter. Horizon Investments LLC now owns 11,886 shares of the industrial products company’s stock valued at $601,000 after purchasing an additional 395 shares during the last quarter. Federated Hermes Inc. lifted its position in shares of Proto Labs by 1.5% in the fourth quarter. Federated Hermes Inc. now owns 30,748 shares of the industrial products company’s stock worth $1,556,000 after purchasing an additional 469 shares in the last quarter. Group One Trading LLC bought a new stake in shares of Proto Labs in the fourth quarter worth $25,000. Finally, Creative Planning boosted its holdings in Proto Labs by 9.0% during the third quarter. Creative Planning now owns 6,883 shares of the industrial products company’s stock worth $344,000 after purchasing an additional 569 shares during the last quarter. Institutional investors own 84.54% of the company’s stock.
Analyst Upgrades and Downgrades
Several brokerages have issued reports on PRLB. Zacks Research upgraded shares of Proto Labs from a “hold” rating to a “strong-buy” rating in a research note on Thursday, August 6th. Benchmark raised their price objective on Proto Labs from $70.00 to $91.00 and gave the company a “buy” rating in a report on Thursday, July 2nd. Needham & Company LLC raised Proto Labs from a “hold” rating to a “buy” rating and set a $87.00 target price on the stock in a research report on Monday, August 3rd. Wall Street Zen lowered Proto Labs from a “strong-buy” rating to a “buy” rating in a report on Saturday, July 18th. Finally, Weiss Ratings lowered Proto Labs from a “buy (b)” rating to a “buy (b-)” rating in a report on Tuesday, August 18th. One analyst has rated the stock with a Strong Buy rating and three have given a Buy rating to the stock. According to data from MarketBeat, Proto Labs presently has a consensus rating of “Buy” and a consensus target price of $89.00.
Proto Labs Trading Up 1.3%
Shares of PRLB opened at $78.63 on Thursday. The company has a market cap of $1.88 billion, a price-to-earnings ratio of 62.90 and a beta of 1.40. Proto Labs, Inc. has a 1-year low of $45.10 and a 1-year high of $93.00. The company’s fifty day simple moving average is $80.47 and its 200 day simple moving average is $70.82.
Proto Labs (NYSE:PRLB – Get Free Report) last posted its quarterly earnings results on Friday, July 31st. The industrial products company reported $0.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.53 by $0.07. Proto Labs had a net margin of 5.44% and a return on equity of 4.80%. The firm had revenue of $149.34 million for the quarter, compared to analyst estimates of $144.53 million. During the same period in the prior year, the firm posted $0.41 earnings per share. The company’s quarterly revenue was up 10.5% compared to the same quarter last year. Proto Labs has set its Q3 2026 guidance at 0.560-0.640 EPS. As a group, research analysts forecast that Proto Labs, Inc. will post 1.46 earnings per share for the current year.
Insider Activity
In other news, Director Sven Wehrwein sold 2,000 shares of the company’s stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $77.28, for a total value of $154,560.00. Following the sale, the director directly owned 32,505 shares of the company’s stock, valued at approximately $2,511,986.40. This represents a 5.80% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.30% of the company’s stock.
About Proto Labs
Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.
Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.
See Also
- Five stocks we like better than Proto Labs
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.
